New Studies Indicate Marijuana Is Promising Therapy For Treating Tourette Syndrome

Patients with Tourette syndrome (TS) can potentially benefit from the use of cannabis-based medicine, according to new studies reported by Marijuana Moment.

TS is a neurodevelopmental disorder characterized by motor and phonic tics that affects between 0.3% and 0.7% of children.

A new scientific review published last month in the European Journal of Clinical Pharmacology evaluated nine studies involving 401 patients with the condition.  The research included clinical trials and cohort studies, analyzing measurements before and after cannabinoid intake and assessing significance with a 95 percent confidence interval.

“The current study indicates promising and potentially effective outcomes with the use of cannabis-based medicine in mitigating the severity of tics and premonitory urges,” the researchers concluded. “However, there is a need for larger, placebo-controlled studies with more representative samples to validate these findings.”

The research was believed to be “the first systematic review and meta-analysis evaluating the effectiveness of CBM among patients with TS using various scales,” the authors said.

They noted that while TS is currently incurable, there are established treatment options available, including behavioral therapy and neuroleptics, and added that the use of cannabis-based medicine for tic management is an emerging therapeutic strategy.

A number of states have listed TS as a qualifying condition for the use of medical marijuana, the report points out.

Cannabutter Digest has all the news you need to stay up to date on the latest cannabis industry trends. Check back often for delicious recipes, exciting new products, and more of the news you can use!